We found a strong inducing effect of YY1 expression in the cell cycle (31%), apoptosis (16%), and DNA damage (16%) pathways across different cancers, as well as a potent inhibitory effect on the RASMAPK (19%), EMT (12%), hormone ER (12%), and RTK (12%) pathways. The gene discussed is YY1; the disease is cancer.